


Certolizumab Pegol Promising for Plaque Psoriasis in Phase 3 Trial

Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept

FDA Update on Rituximab & Etanercept; Plus New ACP Gout Guideline

Reinitiating TNF Blockers after Tuberculosis Treatment
Big Pharma vs. Big Pharma in Court Battles over Biosimilar Drugs

FDA Approves Etanercept-szzs Biosimilar
U.S. FDA Approves Biosimilar to Etanercept

Tildrakizumab Promising for Plaque Psoriasis; FDA Approves Adalimumab to Treat Panuveitis
